TP53 and intrahepatic cholangiocarcinoma: Apostolou et al. (42), together with Norimatsu et al. (43), suggested a score-based method by merging ICC evaluations for Ki-67/p53 through cytology-based imprints collected from extracted uteri with finalized scorings valuable within diagnoses.